Clinical Trial Update: Mechanism of Fatty Acid-induced Impairment of Glucose-simulated Insulin Secretion - Effect of Buphenyl [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the mechanism of fatty acid–induced impairment of glucose-stimulated insulin secretion and the effect of Buphenyl on thi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Insulin Resistance

Drugs mentioned

• BUPHENYL (Sodium phenylbutyrate)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Diabetes, Insulin Resistance | Phase 4 | Status: COMPLETED